Navigation Links
Pain Patches Making Gains in U.S.
Date:1/21/2011

By Dennis Thompson
HealthDay Reporter

FRIDAY, Jan. 21 (HealthDay News) -- Americans suffering from muscle pain are used to taking a pill or rubbing in a cream to help soothe their aches.

But a new form of pain relief seems to be catching on: analgesics delivered through a medicated patch placed directly where it hurts.

The U.S. Food and Drug Administration approved the country's first over-the-counter, pain-relieving transdermal patches in 2008. But the patches, marketed under the brand name Salonpas, are nothing new. They've been sold in various countries in Asia since the 1930s, according to their manufacturer, the Japanese firm Hisamitsu Pharmaceutical.

"Salonpas is the Western world catching up with Asia," said Dr. Rick Rosenquist, a professor of anesthesia and director of pain medicine at the University of Iowa Carver College of Medicine and chairman of the American Society of Anesthesiologists' committee on pain medicine.

"If you are an Asian kid, you've had these placed on you since time immemorial," he said. "It's just now starting to hit more mainstream in the United States. They're gaining more acceptance."

Before the FDA action, pain-relieving patches were available in the United States only by prescription, said Dr. John Dombrowski, director of the Washington Pain Center in Washington, D.C. Their active ingredients include such medications as lidocaine, capsaicin and non-steroidal anti-inflammatory drugs, or NSAIDs. The active ingredients in Salonpas are methyl salicylate and menthol, common components of pain-relieving gels and creams, such as Bengay.

Pain patches have a number of benefits, Rosenquist and Dombrowski said, not the least of which is convenience. With a patch, you "put [it] on and forget about it, rather than having to remember to take pills," Dombrowski said.

The patches also deliver their medicine directly to the site of a person's pain. This may eliminate some of the side effects that come with taking pills. For instance, some analgesics are likely to cause an upset stomach unless they're taken with food. "Obviously, patches get around that," he said. "It's a very clever way of getting the medications right where they need to be."

And, because patches release their medication slowly into the body through the skin, people also should get more consistent pain relief than they do with pills.

On the other hand, people have to be sure to carefully follow instructions for using the patches, to avoid overdose.

The main downside to pain patches, however, apparently comes from their effect on the skin. Some people may find themselves allergic to either the active ingredient in a patch or the adhesive used to keep the patch on the body.

"You need to pay attention when you put them on, to see if you have any kind of skin reaction to the compounds that are contained in the patch," Rosenquist said.

Both doctors said that they expect more over-the-counter pain patches to hit the market if the popularity of Salonpas continues to grow. Future over-the-counter options, they predicted, could include reduced-dosage versions of the NSAID-delivering patches now available through prescription.

"Success begets success," Dombrowski said. "If this does very well, other drug companies will say, 'I want a piece of this action.'"

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about pain.

SOURCES: Rick Rosenquist, M.D., professor, anesthesia, and director, Center for Pain Medicine and Regional Anesthesia, Carver College of Medicine, University of Iowa, Iowa City, Iowa; John Dombrowski, M.D., director, Washington Pain Center, Washington, D.C.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Health-care systems not using best evidence in decision-making
2. New method for making large quantities of deuterium-depleted drinking water
3. ICU communication study reveals complexities of family decision-making
4. Study Confirms It: Booze Impairs Decision-Making
5. Neurons cast votes to guide decision-making
6. Is your job making you fat?
7. Mayo Clinic review of ethical decision making with end-of-life care
8. Experts urge making cigarettes non-addictive a research priority
9. US hospitals making only modest gains in adoption of electronic health records
10. Clinical trials abroad: Making non-English language consent forms readable
11. Better understanding of mapmaking in the brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pain Patches Making Gains in U.S.
(Date:12/5/2016)... Tampa, FL (PRWEB) , ... December 05, 2016 ... ... Regional Chief Clinical Officer for the Florida Hospital West Florida Region. McGuinness brings ... record in leading and engaging staff, physicians and leaders. , In her new ...
(Date:12/5/2016)... ... December 05, 2016 , ... The legislation – ... direct supervision of a licensed physical therapist, to render care for certain patients. ... treatment plan from a licensed physical therapist (PT) and throughout the treatment cycle ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... to ensure moisture measurements are consistently correct. However, regular performance testing is ... METTLER TOLEDO offers a solution: SmartCal™ . This innovative test substance ...
(Date:12/4/2016)... ... December 02, 2016 , ... ... better access to nutraceuticals and help doctors more efficiently manage their practice. ... practice management software platform for Integrative and Functional Medicine. , The Metabolic ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... at the 2016 Anti-Aging & Beauty Awards at The Aesthetic & ... & Anti-Aging Medicine European Congress (AMEC) brings together the industry’s leading scientific ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , December 5, 2016 According to ... Treatment modalities (Chondrocyte Transplantation, Growth Factor Technology, Tissue Scaffolds, Cell-free composites), ... by MarketsandMarkets, the market is projected to reach USD 779.8 Million ... CAGR of 13.5% during the forecast period of 2016 to 2021. ... ...
(Date:12/5/2016)... 5, 2016 According to a new report published by ... - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", the global surgical ... $5,255 million by 2022, growing at a CAGR of 6.4% from 2016 to ... share. Continue Reading ... ...
(Date:12/5/2016)... PUNE, India , December 5, 2016 /PRNewswire/ ... Market Research, titled, "Global Cancer Biomarkers Market - Global Opportunity ... biomarkers market is projected to reach $15,737 million by 2022 ... from 2016 to 2022. Omic technologies segment accounted for more ... expected to maintain its dominance during the forecast period. ...
Breaking Medicine Technology: